Fecal Incontinence
Conditions
Keywords
anorectal physiology, therapies, quality fo life
Brief summary
This is a RCT aimed to assessing efficacy of kegel exercises,biofeedback, electrostimulation and transcutaneous neuromodulation on women with fecal incontinence, measuring its impact on anorectal physiology, cortical plasticity, clmical severity and the quality of life.
Detailed description
Fecal incontinence is a prevalent condition with a major impact on quality of life. Currently four treatments are being used in clinical practice: Kegel exercises (K), biofeedback (BF), electrostimulation (ES) and transcutaneous neuromodulation (NM). Results in the literature are discordant and lack methodological rigour making scientific evidence weak. The aim of this study is to assess the efficacy of these four treatments on community-dwelling women and their impact on anorectal physiology, on clinical severity and on QoL. This is a randomized control trial. Patient physiology was studied with anorectal manometry and endoanal ultrasonography; clinical severity was assessed with Cleveland and St. Mark's scales, and QoL with the Faecal Incontinence Quality of Life (FIQL) and the EuroQol's EQ5D questionnaires. Urinary incontinence (UI) was also evaluated by means of International Consultation on Incontinence (ICIQ) score. Patients were randomized and assigned to K (control), BF+K, ES+K or NM+K, given active treatment for a 3-month period, and then evaluated again with identical tests and parameters to identify changes.
Interventions
The aim is to compare how each treatment improves symptoms and quality of life and which physiologic mechanisms affects. The basal treatment which other therapies are compared to is Kegel.
Sponsors
Hospital de Mataró
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Age higher than 18 * To be woman * Have had incontinence episiodes at least from 6 month since the beginning of the study * Have had incontinence episodes during the last month prior the beginning of the study * The patient is able to understand the nature and impliations of the study and, therefore, to decide her participation.
Exclusion criteria
* Not meeting inclusion criteria * Have very mild condition (Wexner \<4) * To be unable to perform / understand the treatments properly * Being pregnant * To have used treatmets for fecal incontinence within the last six months prior to the start of the study * If, at reserarcher's criteria, the patient has not the proper conditions to perform and finish the treatments.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| clinical severity | Changes of severity after 3 month-treatment | severity of the symptoms measured with Cleveland score |
| maximum anal resting pressure | Changes maximum anal resting pressure after 3 month-treatment | pressure of the anal canal measured with mmHg |
| maximum squeeze pressure | Changes maximum squeeze pressure after 3 month-treatment | pressure on the anal canal when squeezing measured with mmHg |
| rectal sensitivity | changes in rectal balloon filling after 3 month-treatment | patient's rectal perception, measured with cm3 of distention of a rectal balloon |
Outcome results
None listed